Uromed (US) launches incontinence device in Germany:
This article was originally published in Clinica
Uromed (US) is to launch its Reliance Insert incontinence device in Germany this autumn. The single-use, balloon-tipped device is inserted into the urethra with a reusable applicator which, when depressed, inflates the balloon. The insert is removed to allow urination by pulling on a string which deflates the balloon. Average use is expected to be three times daily. The Reliance is indicated for stress urinary incontinence for patients unwilling to undergo surgery or as a stopgap before surgery. UroMed has filed for a 510(k) in the US and hopes to launch the device in other countries this year. Some 8.5 million women in the US suffer urinary incontinence.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.